|
Leventhal, A M; David, S P; Brightman, M et al. (2012) Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. Pharmacogenomics J 12:86-92
|
|
Li, Yimei; Wileyto, E Paul; Heitjan, Daniel F (2010) Modeling smoking cessation data with alternating states and a cure fraction using frailty models. Stat Med 29:627-38
|
|
Cohn, Amy M; Strong, David R; Abrantes, Ana M et al. (2010) History of single episode and recurrent major depressive disorder among smokers in cessation treatment: Associations with depressive symptomatology and early cessation failure. Addict Disord Their Treat 9:41-52
|
|
Strong, David R; Kahler, Christopher W; Leventhal, Adam M et al. (2009) Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment. Nicotine Tob Res 11:1142-53
|
|
Uhl, George R; Liu, Qing-Rong; Drgon, Tomas et al. (2008) Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry 65:683-93
|
|
Uhl, George R; Drgon, Tomas; Johnson, Catherine et al. (2008) Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify ""connectivity constellation"" and drug target genes with pleiotropic effects. Ann N Y Acad Sci 1141:318-81
|
|
David, Sean P; Brown, Richard A; Papandonatos, George D et al. (2007) Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res 9:821-33
|
|
Kassel, Jon D; Yates, Marisa; Brown, Richard A (2007) Baseline reaction time predicts 12-month smoking cessation outcome in formerly depressed smokers. Psychol Addict Behav 21:415-9
|
|
David, Sean P; Strong, David R; Munafo, Marcus R et al. (2007) Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine Tob Res 9:1251-7
|
|
Brown, Richard A; Niaura, Raymond; Lloyd-Richardson, Elizabeth E et al. (2007) Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine Tob Res 9:721-30
|
Showing the most recent 10 out of 26 publications
